CCR5 and HIV infectious disease: Overall, this suggests that a) dopamine-mediated changes in CCR5 could be the mechanism by which dopamine increases HIV infection and b) if the variation in the impact of dopamine on myeloid susceptibility to HIV infection is connected to the dopaminergic impact on CCR5, it is likely to vary between individuals, similarly to the dopamine-mediated influence on maraviroc efficacy.